Work

GLP-1 agonists to slow down Parkinson’s progression? The quest continues

Year: 2025

Type: article

Source: Med

DOI: 10.1016/j.medj.2025.100645

Authors: Bastiaan R. Bloem, Eric A. Macklin, Michael A. Schwarzschild

Institutions: Radboud University Nijmegen, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Harvard University, Massachusetts General Hospital

Language: Norwegian

Topic: Parkinson's Disease Mechanisms and Treatments

Subfield: Clinical Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Parkinson's Foundation, Farmer Family Foundation

OpenAlex ID: W4409381873

FWCI: 7.517

Cites: 14

Cited by: 14

Related to: 10